Navigation Links
Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update
Date:5/14/2013

BOONTON, N.J., May 14, 2013 /PRNewswire/ -- Unigene Laboratories, Inc. (PINK: UGNE) today announced financial results for the first quarter ended March 31, 2013 and provided a corporate update on the Company's financial status and strategic initiatives. 

Ashleigh Palmer, Unigene's Chief Executive Officer, commented, "2013 has been extremely challenging for Unigene.  The FDA advisory committee recommendation against calcitonin containing products, followed by an Article 9 sale of our Biotechnologies strategic business unit (SBU) assets to affiliates of Victory Park Capital (VPC), has had a materially negative impact on the Company."

Palmer continued, "Nevertheless, we continue to pursue the limited strategic options available to us.  In particular, we continue to try to monetize the therapeutic assets that remain within Unigene, in particular, our oral PTH program, and UGP281.  We also recently announced an equity transfer and exclusive license agreement with Nordic Bioscience and its affiliate, resulting in $1.0 million in proceeds that were used to pay down VPC debt.  VPC has since re-loaned $500,000 of these proceeds back to us.  Our mission going forward is to seek similar opportunities to infuse cash into the Company to maximize our lender and shareholder value."

"However, as previously stated, unless there is a near-term restructuring of the debt owed to VPC and the Company's founders, we will no longer have the ability to continue as a going concern.  Regardless of whether VPC and the Company's founders arrive at a settlement to resolve Unigene's debt situation, the $500,000 re-loaned by VPC following the Nordic transaction will only be sufficient to finance the Company through mid-June, 2013."

FIRST QUARTER 2013 FINANCIAL & OPERATIONAL SUMMARYUnigene generated net income of $1.98 million for the three months ended March 31, 2013 or $0.02 per share as compared to a net loss of $3.2 mil
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
2. Unigene Announces Fourth Quarter and Full-Year 2012 Results
3. Unigene Receives 2013 Drug Delivery Partnerships Industry Achievement Award
4. Unigene Recieves 2013 Drug Delivery Partnerships Industry Achievement Award
5. Unigenes Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone
6. Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127
7. Unigene to Announce Third Quarter 2012 Financial Results on November 20, 2012
8. Unigene To Present at the 2012 Obesity Societys 30th Annual Scientific Meeting
9. Unigene and Tarix Pharmaceuticals Report Highly Increased Oral Bioavailability of "Peptelligence-engineered" TXA127
10. Unigene Provides Update Following Recent EMA Recommendation on Calcitonin-Containing Medicines
11. Unigenes Oral PTH Phase 2 Proof-of-Concept Data to be Presented at Upcoming Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3,  2015 About ... bio-artificial devices, which are implanted or integrated ... organs. These include artificial heart, kidney, pancreas, ... polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ... artificial organs. These organs are incorporated with ...
(Date:9/3/2015)... 3, 2015 About dry eye syndrome Dry ... to deficient tear production or quick tear evaporation or ... types: aqueous tear deficient dry eye and evaporative dry ... do not produce enough tears, whereas meibomian gland dysfunction ... to slow tear evaporation and maintain tear stability. The ...
(Date:9/3/2015)... Sept. 3, 2015  Ascendis Pharma A/S ... biotechnology company that applies its innovative TransCon ... today announced plans to present at several ... Healthcare Conference in BostonDate: , Thursday, September ... of America Merrill Lynch Global Healthcare Conference ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
... WIRE)--May 21, 2007 - Cougar Biotechnology,Inc. (OTCBB:CGRB) today ... on the Company's prostate cancer drug candidate CB7630,(abiraterone ... Annual Meeting, which is currently taking place,in Anaheim, ... A.,Yap from the Cancer Research UK Centre for ...
... 40/12.5 and 40/25 mg/day and Amlodipine +,Benazepril ... Society of,Hypertension Twenty-Second Annual Scientific Meeting, PARSIPPANY, ... data,presented today at the American Society of ... Chicago,demonstrated that the fixed-dose combination Benicar HCT,(olmesartan ...
Cached Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Keeping mold ... and around the home is quite common. Mold can grow anywhere - on carpet, ... leaking pipes. Checking for excessive moisture and water in the home is key to ...
(Date:9/4/2015)... PA (PRWEB) , ... September 04, 2015 , ... Many consumers are looking for a ... could be their solution. , The patent-pending K Med Cups provide a quick and simple ... help to relieve a cold, flu or cough. As a result, they enhance comfort and ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Having access to ... has led to an increasing amount of unnecessary emergency room visits which affects hospitals’ ... taxes the country’s health bill. Fortunately, a solution to alleviate this problem has recently ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... comparison to settlements under the Stark physician self-referral law. “Stark Law DOs ... webinar from Atlantic Information Services, Inc. (AIS), will detail which deals are attracting ...
(Date:9/4/2015)... ... , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg celebrated their ... supporting families affected by autism, raising nearly $250,000. , 150 guests, including event ... Oscar Swan Inn to support the cause. , McCarthy tugged the heartstrings of ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... active women WHITE PLAINS, N.Y., May 4 As a brand ... introduction of Vagisil S atin ... long-lasting relief from itch and irritation, as it soothes and helps ... Satin comes in a unique easy-to-use and discrete pump. ...
... May 4 On April 29, 2009, the United ... (Houston), ordered the dismissal of a previously disclosed antitrust ... three other current or former independent casket retailers against ... Hillenbrand, Inc. (NYSE: HI )The Pioneer Valley ...
... greater risk , than they might think SCHAUMBURG, Ill., ... million cases of skin cancer will ... those most at risk for developing skin cancer are fair-skinned ... older populations, dermatologists advise that those who do not fit ...
... published in the May issue of the Journal ... dramatic disparities in breast cancer outcomes continue to exist ... they are diagnosed, extent of the cancer, type of ... population-based analysis of breast cancer outcomes data to date, ...
... now record and track treatment progress between office visits wherever Internet access ... ... -- Hemophilia A patients and their treatment providers are now better able ... from CSL Behring. Patients can now track and record their treatment ...
... sedentary lifestyles and not drinking enough water are to ... received a call from her daughter,s daycare saying that ... dreamt the cause would be a condition often associated ... was doubled over in pain and saying that her ...
Cached Medicine News:Health News:Feminine Hygiene Brand Leader Helps Women Restore Their Feminine Self With Launch of Vagisil Satin(TM) 2Health News:Federal District Judge Dismisses Antitrust Lawsuit Against Batesville Casket Company 2Health News:Consumer Alert: Dermatologists Warn Skin Cancer is an Equal-Opportunity Health Threat 2Health News:Consumer Alert: Dermatologists Warn Skin Cancer is an Equal-Opportunity Health Threat 3Health News:Consumer Alert: Dermatologists Warn Skin Cancer is an Equal-Opportunity Health Threat 4Health News:Consumer Alert: Dermatologists Warn Skin Cancer is an Equal-Opportunity Health Threat 5Health News:African-American women still have poorer breast cancer outcomes 2Health News:African-American women still have poorer breast cancer outcomes 3Health News:Patient Convenience Focus of New Upgrades to HeliTrax System by CSL Behring 2Health News:Patient Convenience Focus of New Upgrades to HeliTrax System by CSL Behring 3Health News:Patient Convenience Focus of New Upgrades to HeliTrax System by CSL Behring 4Health News:Kidney Stones in Children on The Rise, U-M Expert Says 2Health News:Kidney Stones in Children on The Rise, U-M Expert Says 3
Revised Drug calibrator that replaces existing Drug calibrator - this product contains Lithium in addition to Digoxin, Phenobarbital, OPhenytoin, & Theophulline....
For the qualitative and semi-quantitative measurement of RF in human serum....
... The BD Macro-Vue RPR (Rapid ... and Tear-drop Tests are nontreponemal testing ... syphilis described in A Manual of ... in this manual are the most ...
... The BD Macro-Vue RPR (Rapid Plasma ... Tear-drop Tests are nontreponemal testing procedures ... described in A Manual of Tests ... this manual are the most widely ...
Medicine Products: